The innovative drug sector of Hong Kong stocks rose. Genting Xinyao is now up 48%, China Biopharmaceuticals is up 17%, CSPC Pharmaceuticals is up more than 13%, and Fosun Pharmaceuticals is up 7%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.